Skip to main content
John Sunwoo, MD, Otolaryngology (ENT), Palo Alto, CA

John Bing Sunwoo MD

Head & Neck Oncologic Surgery, Head & Neck Plastic Surgery


Edward C. and Amy H. Sewall Professor and Associate Dean for Academic Affairs at Stanford University

Join to view full profile
  • 300 Pasteur Dr# MC5500Palo Alto, CA 94305

  • Phone+1 650-498-6000

  • Fax+1 650-498-5840

Dr. Sunwoo is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Otolaryngology - Head and Neck Surgery, 1997 - 2003
  • WashU Medicine
    WashU MedicineClass of 1993

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2008 - 2028
  • MD State Medical License
    MD State Medical License 1998 - 2001
  • Otolaryngology
    American Board of Otolaryngology - Head and Neck Surgery Otolaryngology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012-2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012-2014, 2016-2017
  • Regional Top Doctor Castle Connolly, 2014

Publications & Presentations

PubMed

Journal Articles

  • A Novel Cross-Correlation Methodology for Assessing Biophysical Responses Associated with Pain  
    Lonnie K Zeltzer, Roberta M Kato, Jon Detterich, Thomas D Coates, John Sunwoo, John C Wood, Journal of Pain Research

Press Mentions

  • Heavy Cannabis Use Linked to High Risk of Head, Neck Cancers
    Heavy Cannabis Use Linked to High Risk of Head, Neck CancersAugust 12th, 2024
  • Indapta Therapeutics Announces New Preclinical Data Demonstrating Proprietary G-NK Cells Enhance Efficacy of Monoclonal Antibodies in Multiple Myeloma
    Indapta Therapeutics Announces New Preclinical Data Demonstrating Proprietary G-NK Cells Enhance Efficacy of Monoclonal Antibodies in Multiple MyelomaAugust 10th, 2021
  • Boosted NK Cells Crush Solid Tumors in Mice
    Boosted NK Cells Crush Solid Tumors in MiceJune 16th, 2026

Grant Support

  • Pacific-Stanford PRIMED Program: Training the next generation of clinical oral health researchersUNIVERSITY OF THE PACIFIC-STOCKTON2023–2028
  • Reprogramming the Tumor-Immune Interface in Oral CancerSTANFORD UNIVERSITY2020–2028
  • Preclinical microphysiological tumor models for nuclear medicineSTANFORD UNIVERSITY2023–2027
  • Preclinical microphysiological tumor models for nuclear medicineSTANFORD UNIVERSITY2023–2027

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: